Filtros : "Current Pharmaceutical Design" "ICB-BMF" Limpar

Filtros



Refine with date range


  • Source: Current Pharmaceutical Design. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TREVELIN, Silvia Cellone e LOPES, Lucia Rossetti. Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, v. 21, n. 41, p. 5951-5963, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666151029112523. Acesso em: 16 nov. 2025.
    • APA

      Trevelin, S. C., & Lopes, L. R. (2015). Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, 21( 41), 5951-5963. doi:10.2174/1381612821666151029112523
    • NLM

      Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666151029112523
    • Vancouver

      Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666151029112523
  • Source: Current Pharmaceutical Design. Unidade: ICB

    Subjects: FARMACOLOGIA, PEPTIDEOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOPES, Luciana Biagini e CARVALHO, Vanessa Freitas Mendonça de e LEMOS, Débora P. de. Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, v. 21, n. 20, p. 2814-2822, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150428143243. Acesso em: 16 nov. 2025.
    • APA

      Lopes, L. B., Carvalho, V. F. M. de, & Lemos, D. P. de. (2015). Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, 21( 20), 2814-2822. doi:10.2174/1381612821666150428143243
    • NLM

      Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150428143243
    • Vancouver

      Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150428143243

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025